Capitol Health Dirección

Dirección controles de criterios 3/4

El CEO de Capitol Health's es Justin Walter , nombrado en Jul 2019, tiene una permanencia de 4.75 años. compensación anual total es A$1.55M, compuesta por 43.3% salario y 56.7% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.44% de las acciones de la empresa, por valor de A$1.03M. La antigüedad media del equipo directivo y de la junta directiva es de 4.8 años y 4.8 años, respectivamente.

Información clave

Justin Walter

Chief Executive Officer (CEO)

AU$1.6m

Compensación total

Porcentaje del salario del CEO	43.3%
Permanencia del CEO	4.8yrs
Participación del CEO	0.4%
Permanencia media de la dirección	4.8yrs
Promedio de permanencia en la Junta Directiva	4.8yrs

Actualizaciones recientes de la dirección

Have Insiders Been Selling Capitol Health Limited (ASX:CAJ) Shares This Year?

Feb 14

Recent updates

Capitol Health Limited's (ASX:CAJ) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Mar 05

Have Insiders Been Selling Capitol Health Limited (ASX:CAJ) Shares This Year?

Feb 14

Did You Miss Capitol Health's (ASX:CAJ) 20% Share Price Gain?

Jan 19

Is Capitol Health Limited's (ASX:CAJ) Shareholder Ownership Skewed Towards Insiders?

Dec 22

Capitol Health Limited's (ASX:CAJ) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Dec 01

Here's Why We Don't Think Capitol Health's (ASX:CAJ) Statutory Earnings Reflect Its Underlying Earnings Potential

Aug 17

Is Now An Opportune Moment To Examine Capitol Health Limited (ASX:CAJ)?

Jul 25

Is Capitol Health Limited's (ASX:CAJ) Latest Stock Performance A Reflection Of Its Financial Health?

Jul 04

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Justin Walter en comparación con los beneficios de Capitol Health?
Fecha	Compensación total	Salario	Ingresos de la empresa
Dec 31 2023	n/a	n/a	AU$6m
Sep 30 2023	n/a	n/a	-AU$3m
Jun 30 2023	AU$2m	AU$673k	-AU$11m
Mar 31 2023	n/a	n/a	-AU$12m
Dec 31 2022	n/a	n/a	-AU$12m
Sep 30 2022	n/a	n/a	-AU$853k
Jun 30 2022	AU$1m	AU$670k	AU$11m
Mar 31 2022	n/a	n/a	AU$12m
Dec 31 2021	n/a	n/a	AU$14m
Sep 30 2021	n/a	n/a	AU$13m
Jun 30 2021	AU$2m	AU$673k	AU$12m
Mar 31 2021	n/a	n/a	AU$8m
Dec 31 2020	n/a	n/a	AU$4m
Sep 30 2020	n/a	n/a	AU$3m
Jun 30 2020	AU$1m	AU$592k	AU$865k
Mar 31 2020	n/a	n/a	AU$8m
Dec 31 2019	n/a	n/a	AU$15m
Sep 30 2019	n/a	n/a	AU$20m
Jun 30 2019	AU$390k	AU$58k	AU$24m

Compensación vs. Mercado: La compensación total de Justin($USD1.00M) está por encima de la media de empresas de tamaño similar en el mercado Australian ($USD625.62K).

Compensación vs. Ingresos: La compensación de Justin ha sido consistente con los resultados de la empresa en el último año.

CEO

Justin Walter

4.8yrs

Permanencia

AU$1,553,726

Compensación

Mr. Justin Samuel Walter, BN (Hons), MPH (JCU), served as Director for Enlitic, Inc. since 2022. He has been the Chief Executive Officer, Managing Director and a Director at Capitol Health Limited since Ju...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Justin Walter	CEO, MD & Director	4.8yrs	AU$1.55m	0.44% A$ 1.1m
Brendon Pentland	Chief Financial Officer	less than a year	sin datos	sin datos
Melanie Leydin	Company Secretary	6.8yrs	sin datos	sin datos

4.8yrs

Permanencia media

Equipo directivo experimentado: El equipo directivo de CAJ se considera experimentado (4.8 años antigüedad media).

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Justin Walter	CEO, MD & Director	4.8yrs	AU$1.55m	0.44% A$ 1.1m
Andrew Demetriou	Non-Executive Chairman	9.5yrs	AU$265.00k	0.019% A$ 48.0k
Laura McBain	Independent Non-Executive Director	2.8yrs	AU$110.00k	0.011% A$ 27.6k
Richard Loveridge	Independent Non-Executive Director	6.7yrs	AU$125.00k	0.062% A$ 157.5k
Kai-Chung Shaw	Independent Non-Executive Director	2.7yrs	AU$110.00k	sin datos

4.8yrs

Permanencia media

Junta con experiencia: La junta directiva de CAJ se considera experimentada (4.8 años de antigüedad promedio).

Capitol Health Dirección

Dirección controles de criterios 3/4

Información clave

Actualizaciones recientes de la dirección

Capitol Health Limited Appoints Brendon Pentland as the Chief Financial Officer, Effective 1 April 2024

Capitol Health Limited Announces the Resignation of Craig Bremner as Chief Financial Officer

Capitol Health Limited, Annual General Meeting, Nov 15, 2023

Capitol Health Limited, Annual General Meeting, Nov 15, 2022

Have Insiders Been Selling Capitol Health Limited (ASX:CAJ) Shares This Year?

Capitol Health Limited Appoints Craig Bremner as Chief Financial Officer, November 9, 2020

Recent updates

Now 21% undervalued after recent price drop

Now 21% undervalued

First half dividend of AU$0.005 announced

First half 2024 earnings released: EPS: AU$0.002 (vs AU$0.015 loss in 1H 2023)

New major risk - Financial position

Now 20% undervalued

Capitol Health Limited to Report First Half, 2024 Results on Feb 29, 2024

Capitol Health Limited Appoints Brendon Pentland as the Chief Financial Officer, Effective 1 April 2024

Capitol Health Limited's (ASX:CAJ) Popularity With Investors Is Clear

Capitol Health (ASX:CAJ) Takes On Some Risk With Its Use Of Debt

Now 21% undervalued

Now 21% undervalued after recent price drop

Capitol Health Limited Announces the Resignation of Craig Bremner as Chief Financial Officer

Now 20% undervalued after recent price drop

Now 20% undervalued after recent price drop

Price target decreased by 9.8% to AU$0.28

Capitol Health Limited, Annual General Meeting, Nov 15, 2023

Full year 2023 earnings: EPS misses analyst expectations

Capitol Health Limited to Report Fiscal Year 2023 Results on Aug 24, 2023

Price target decreased by 9.6% to AU$0.33

Capitol Health Limited to Report First Half, 2023 Results on Feb 23, 2023

Now 21% undervalued

Now 21% undervalued

Capitol Health Limited (ASX:CAJ) completed the acquisition of Future Medical Imaging Group Pty Ltd.

Is Capitol Health Limited (ASX:CAJ) Worth AU$0.3 Based On Its Intrinsic Value?

Capitol Health Limited Declares Franked Dividend for the Six Months Ended June 30, 2022, Payable on October 21, 2022

Price target increased to AU$0.43

Capitol Health Limited, Annual General Meeting, Nov 15, 2022

Full year 2022 earnings: EPS misses analyst expectations

Capitol Health Limited Announces Dividend for the Six Months Ended June 30, 2022, Payable on 21 October, 2022

Consensus EPS estimates fall by 12%

First half 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Capitol Health Limited Announces Dividend for the Six Months Ended December 31, 2021, Payable on April 1, 2022

Capitol Health Limited to Report First Half, 2022 Results on Feb 24, 2022

Full year 2021 earnings released: EPS AU$0.012 (vs AU$0.001 in FY 2020)

Capitol Health (ASX:CAJ) Seems To Use Debt Rather Sparingly

Should You Investigate Capitol Health Limited (ASX:CAJ) At AU$0.37?

Capitol Health Limited's (ASX:CAJ) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Analysts increase EPS estimates to AU$0.012

First half 2021 earnings released: EPS AU$0.006 (vs AU$0.004 in 1H 2020)

Price target raised to AU$0.36

New 90-day high: AU$0.34

Have Insiders Been Selling Capitol Health Limited (ASX:CAJ) Shares This Year?

Capitol Health Limited (ASX:CAJ) acquired Direct Radiology.

Capitol Health Limited to Report First Half, 2021 Results on Feb 24, 2021

New 90-day high: AU$0.28

Did You Miss Capitol Health's (ASX:CAJ) 20% Share Price Gain?

Is Capitol Health Limited's (ASX:CAJ) Shareholder Ownership Skewed Towards Insiders?

Capitol Health Limited's (ASX:CAJ) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Price target raised to AU$0.31

Capitol Health Limited (ASX:CAJ) entered into a binding agreement to acquire Direct Radiology for AUD 12 million.

Capitol Health Limited (ASX:CAJ) entered into a binding agreement to acquire Direct Radiology for AUD 12 million.

New 90-day high: AU$0.27

Capitol Health Limited Appoints Craig Bremner as Chief Financial Officer, November 9, 2020

Capitol Health Limited Announces Resignation of Marcell Judkins as Chief Financial Officer

Price target raised to AU$0.27

Capitol Health Limited (ASX:CAJ) completed the acquisition of 90% stake in Fowler Simmons Radiology.

Here's Why We Don't Think Capitol Health's (ASX:CAJ) Statutory Earnings Reflect Its Underlying Earnings Potential

Capitol Health Limited to Report Fiscal Year 2020 Results on Aug 26, 2020

Is Now An Opportune Moment To Examine Capitol Health Limited (ASX:CAJ)?

Is Capitol Health Limited's (ASX:CAJ) Latest Stock Performance A Reflection Of Its Financial Health?

Análisis de compensación del CEO

CEO

Permanencia

Compensación

Equipo directivo

Permanencia media

Miembros de la Junta

Permanencia media